The magnitude of the coronavirus pandemic and its disastrous economic consequences have forced federal, state, and local governments to cut red tape that was previously hobbling medical innovation. The fact that we and our healthcare system can survive and thrive without these regulations is telling and suggests the red tape should not be restored after the coronavirus is defeated.

Byzantine regulations in America’s supposedly private healthcare system have made it harder than even in some overseas state-run systems to bring medicines to market and to harness new technology to care for patients. But the coronavirus has allowed the Trump administration to break down many unnecessary barriers, providing more flexibility for doctors to determine the best means of care for their patients.